Correlation Between Relmada Therapeutics and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Relmada Therapeutics and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relmada Therapeutics and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relmada Therapeutics and Spero Therapeutics, you can compare the effects of market volatilities on Relmada Therapeutics and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relmada Therapeutics with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relmada Therapeutics and Spero Therapeutics.
Diversification Opportunities for Relmada Therapeutics and Spero Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Relmada and Spero is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Relmada Therapeutics and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Relmada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relmada Therapeutics are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Relmada Therapeutics i.e., Relmada Therapeutics and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Relmada Therapeutics and Spero Therapeutics
Given the investment horizon of 90 days Relmada Therapeutics is expected to under-perform the Spero Therapeutics. In addition to that, Relmada Therapeutics is 1.1 times more volatile than Spero Therapeutics. It trades about -0.23 of its total potential returns per unit of risk. Spero Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest 86.00 in Spero Therapeutics on November 28, 2024 and sell it today you would lose (6.00) from holding Spero Therapeutics or give up 6.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relmada Therapeutics vs. Spero Therapeutics
Performance |
| Timeline |
| Relmada Therapeutics |
| Spero Therapeutics |
Relmada Therapeutics and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relmada Therapeutics and Spero Therapeutics
The main advantage of trading using opposite Relmada Therapeutics and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relmada Therapeutics position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Relmada Therapeutics vs. Cytokinetics | Relmada Therapeutics vs. Edgewise Therapeutics | Relmada Therapeutics vs. Dyne Therapeutics | Relmada Therapeutics vs. Third Harmonic Bio |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |